MYD88 and acute kidney injury: Our findings reveal that cilastatin exerts similar effects by downregulating TLR4 expression at both mRNA and protein levels and significantly reducing the expression of the adaptor molecule MyD88, which plays a key role downstream of TLR4 and is implicated in AKI pathogenesis [25].